Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 878 (ZNF878) is a member of the C2H2-type zinc finger family and functions as a DNA-binding transcription factor in humans[3][6][7]. It is predicted to enable sequence-specific binding to DNA, regulating transcription in a manner dependent on RNA polymerase II[3][5][6]. ZNF878 is believed to localize to the nucleus and may have paralogy with ZNF433[3]. No direct links to disease causation or therapeutic targeting have been established, and currently there are no known drugs, biomarkers, or notable safety concerns associated with modulation of this gene or its protein product[3][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 878 (ZNF878).